← All forecasts · October 26–30

CL / Q3 2026 (CapIQ label: FQ3 2026 - Sep 2026)

Colgate-Palmolive Company

Reported: Oct 30, 2026

Forecast published

Opus 5.5 High in Shortcut

Shortcut

0.94

Normalized diluted EPS

+1.1% vs Street

Off by $0.03 per share

Street

0.93

Normalized diluted EPS

October 25 consensus snapshot

Off by $0.04 per share

Real

0.97

Colgate issuer Base Business non-GAAP diluted EPS

Shortcut win

Reported result · Oct 30 ↗ · The issuer explicitly reports Base Business diluted EPS 0.97 versus GAAP diluted 0.94 for Q32026.

USD per diluted common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast.

Shortcut’s reasoning.

Bottom-up segment build: organic sales +3.1% (volume +1.6%, price +1.4%) vs an easy 3Q25 comp (+0.4%); management guided H2 to be more volume-led; North America assumed -2.5% organic, LatAm +5.6%, APAC +5.5% (India strength per Colgate-Palmolive India Sep-26 quarter), Hill's +4.0% as the private-label drag fades.

FX +0.9% from Fed G.5 Jul-Sep 2026 vs 2025 average rates (MXN +7.9%, BRL +6.1% scaled for Argentina drag; INR -8.6%, EUR -1.6%); Prime100 lapped so M&A = 0. Net sales $5,337.7m (+4.0%), in line with $5,334.2m consensus.

Base gross margin 60.1% (+65bp y/y) vs the weak 59.4% 3Q25 comp; CFO said Q3 was 'largely locked in'; advertising step-up keeps base SG&A at 39.3% of sales; base operating margin 20.3% (-36bp), base OP +2.2%.

On the record.

Reporting period
Q3 2026 (CapIQ label: FQ3 2026 - Sep 2026)
Reporting basis
Base Business (non-GAAP) diluted EPS, USD per diluted common share (Income Statement!G124 = G120/G123); matches normalized consensus basis. Net income attribution: Base NI to Colgate = Base NI incl. NCI 781.928 - NCI 31 = 750.928 (G116-G117); GAAP NI 711.428 + SGPP 50 - tax 10 - NCI 0.5 = 750.928 (check G122=0). No currency/ADR conversion; no split.
Consensus snapshot
October 25, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Reviewed workbook
Record history
Forecast generated
Oct 27, 2026 at 6:49 PM PDT
Reviewed revision completed
Oct 27, 2026 at 6:49 PM PDT
First published
Oct 27, 2026 at 10:11 PM PDT
Result basis

The issuer explicitly reports Base Business diluted EPS 0.97 versus GAAP diluted 0.94 for Q32026. Its reconciliation reports attributable Base Business net income 777m after NCI28m, with 799.7m diluted shares. The Strategic Growth and Productivity Program EPS adjustment 0.03 is directly reported, not newly modeled. Prior-year Base Business diluted 0.91 matches the frozenhistory. Existing original share-timing and other modeling judgments stay fixed. The current issuer news page supplied the report despite the stale SECfeed/provider panel.